- Home
- STRRP vs OCEAW Comparison
STRRP vs OCEAW Comparison
Compare STRRP & OCEAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRRP
- OCEAW
- Stock Information
- Founded
- STRRP N/A
- OCEAW N/A
- Country
- STRRP United States
- OCEAW United States
- Employees
- STRRP 171
- OCEAW 7
- Industry
- STRRP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- OCEAW Biotechnology: Pharmaceutical Preparations
- Sector
- STRRP Health Care
- OCEAW Health Care
- Exchange
- STRRP Nasdaq
- OCEAW Nasdaq
- Market Cap
- STRRP N/A
- OCEAW N/A
- IPO Year
- STRRP N/A
- OCEAW 2021
- Fundamental
- Price
- STRRP $9.20
- OCEAW $0.03
- Analyst Decision
- STRRP
- OCEAW
- Analyst Count
- STRRP 0
- OCEAW 0
- Target Price
- STRRP N/A
- OCEAW N/A
- AVG Volume (30 Days)
- STRRP N/A
- OCEAW N/A
- Earning Date
- STRRP N/A
- OCEAW N/A
- Dividend Yield
- STRRP N/A
- OCEAW N/A
- EPS Growth
- STRRP N/A
- OCEAW N/A
- EPS
- STRRP N/A
- OCEAW N/A
- Revenue
- STRRP N/A
- OCEAW N/A
- Revenue This Year
- STRRP N/A
- OCEAW N/A
- Revenue Next Year
- STRRP N/A
- OCEAW N/A
- P/E Ratio
- STRRP N/A
- OCEAW N/A
- Revenue Growth
- STRRP N/A
- OCEAW N/A
- 52 Week Low
- STRRP N/A
- OCEAW N/A
- 52 Week High
- STRRP N/A
- OCEAW N/A
- Technical
- Relative Strength Index (RSI)
- STRRP 48.02
- OCEAW N/A
- Support Level
- STRRP $9.18
- OCEAW N/A
- Resistance Level
- STRRP $9.42
- OCEAW N/A
- Average True Range (ATR)
- STRRP 0.21
- OCEAW 0.00
- MACD
- STRRP -0.04
- OCEAW 0.00
- Stochastic Oscillator
- STRRP 26.93
- OCEAW 0.00
About STRRP Star Equity Holdings Inc. Series A Cumulative Perpetual Preferred Stock
Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.